Hepatocellular carcinoma is the fifth commonest form of malignancy with 750,000 new patients diagnosed worldwide each year and is the 2nd major cause of cancer deaths worldwide. Screening of high risk patients, particularly those with cirrhosis, is well accepted clinically but is often suboptimal. This research theme aims to improve the methodology for performing clinical HCC surveillance. By creating validated and standardised interpretation of the variations in individual patients results we aim improve early HCC detection through accurate and easy to use screening tools.

Items in this Collection

  • Serial serum AFP results for HCC free patients in HCC surveillance cohort 

    Bird, Tom
    Data used for analysis is related submission to PLOS ONE. Ethical approval given for deposition in publicly available repository by local ethics committee. Individual patients each have a series of AFP results (serum) taken ...
  • Serial AFP measurement in confirmed HCC cases 

    Bird, Tom
    This dataset was used in the work to define a Bayesian analysis of serial AFP fluctuations in patients with hepatocellular carcinoma (HCC) in order to improve HCC detection. It consists of all 66 patients whom had AFP ...